menu
    • menu

    Company profile for Porton Advanced Solutions

    NEW Drugs in Dev: 1
    Evonik

    Virtual Booth

    Contact Supplier

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2026-01-12

    Virtual Booth

    Contact Supplier

    End-to-end drug development, specializing in high-potency softgels and liquids, providing global partners with a competitive advantage.

    Virtual Booth

    Contact Supplier

    Kewpie is your partner for Sodium Hyaluronate & Hyaluronic Acid// CEP, USDMF, KDMF & JDMF registered.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-11-03

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Porton Advanced Solutions (Porton Advanced) is a Cell and Gene Therapy (CGT) CDMO. We provide end-to-end process development (PD), analytical development (AD), GMP manufacturing, and testing services to meet clients’ therapeutic product needs at pre-clinical, clinical, and commercial stages.Our dedicated process and analytical development teams have established robust platform-based USP/DSP and GMP manufacturing capability a...
    Porton Advanced Solutions (Porton Advanced) is a Cell and Gene Therapy (CGT) CDMO. We provide end-to-end process development (PD), analytical development (AD), GMP manufacturing, and testing services to meet clients’ therapeutic product needs at pre-clinical, clinical, and commercial stages.Our dedicated process and analytical development teams have established robust platform-based USP/DSP and GMP manufacturing capability and capacity, as well as proprietary technologies to further empower our clients’ successes.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Porton Advanced SolutionsUnited_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    6 Cedarbrook Dr Cranbury Township NJ 08512
    Telephone
    Telephone
    +86 0512 88850385
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://portonadvanced.com/contact-us/
    Linkedin
    Linkedin
    https://www.linkedin.com/company/porton-advanced/
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Tides Asia

    Tides Asia

    Not Confirmed

    envelop Contact Supplier

    Tides Asia

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Porton Advanced and EVA Pharma Sign MOU to CAR T-Cell Therapy
    Porton Advanced and EVA Pharma Sign MOU to CAR T-Cell Therapy

    26 Jun 2025

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/porton-advanced-and-eva-pharma-sign-mou-to-expand-car-t-cell-therapy-access-in-the-middle-east-and-africa-302491979.html

    PR NEWSWIRE
    26 Jun 2025
    Share Share
    Porton Advanced collaborates with TongEYE for iPSC-RPEC therapy
    Porton Advanced collaborates with TongEYE for iPSC-RPEC therapy

    22 May 2025

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/porton-advanced-announces-collaboration-with-tongeye-to-accelerate-development-of-ipsc-rpec-transplantation-therapy-302462976.html

    PR NEWSWIRE
    22 May 2025
    Share Share
    Porton, Hualong Partner on Solid Tumor Cell Therapy
    Porton, Hualong Partner on Solid Tumor Cell Therapy

    19 May 2025

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/porton-advanced-announces-collaboration-with-hualong-biological-to-accelerate-matc-cell-therapy-development-for-solid-tumor-treatment-breakthroughs-302458929.html

    PR NEWSWIRE
    19 May 2025
    Share Share
    Porton Advanced partners with Eureka Therapeutics for TCell Therapy
    Porton Advanced partners with Eureka Therapeutics for TCell Therapy

    19 Mar 2025

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/porton-advanced-announces-collaboration-with-eureka-therapeutics-to-accelerate-tcell-therapy-development-302405703.html

    PR NEWSWIRE
    19 Mar 2025
    Share Share
    Porton And Geneseed Partner To Advance CircRNA Innovative Therapeutics
    Porton And Geneseed Partner To Advance CircRNA Innovative Therapeutics

    30 Jul 2024

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/porton-advanced-and-geneseed-biotech-enter-into-strategic-collaboration-to-focus-on-advancing-circrna-innovative-therapeutics-302209884.html

    PR NEWSWIRE
    30 Jul 2024
    Share Share
    Porton Advanced Introduces MaxCyte ExPERT GTx Flow Electroporation Instrument
    Porton Advanced Introduces MaxCyte ExPERT GTx Flow Electroporation Instrument

    25 Jun 2024

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/porton-advanced-introduces-the-maxcyte-expert-gtx-flow-electroporation-instrument-continuing-to-provide-customers-with-end-to-end-cell-and-gene-therapy-cro--cdmo-services-302180310.html

    PR NEWSWIRE
    25 Jun 2024
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search